- About Us
- Nano-Social Network
- Nano Consulting
- My Account
January 3rd, 2006
A new report warns that as nanotechnology becomes a reality, Europe must not miss the boat, and raises the alarm that the potential benefits of nanomedicine in Europe will be lost without major investment in R&D.
The report, the result of a two-year-long study conducted by the European Science Foundation (ESF), concludes that emerging nanomedicine technologies will increasingly serve as new medical tools for diagnostics and therapeutics in various areas of healthcare including drug discovery and development, drug delivery and providing targeted therapy.
|Related News Press|
Explaining how 2-D materials break at the atomic level January 20th, 2017
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Harris & Harris Group Announces a Proposed Strategic Restructuring December 20th, 2016
New active filaments mimic biology to transport nano-cargo: A new design for a fully biocompatible motility engine transports colloidal particles faster than diffusion with active filaments January 11th, 2017